{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:33:23Z","timestamp":1760056403007,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ncl.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T18:26:57Z","timestamp":1595269617000},"page":"697-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential Diagnoses of Inclusion Body Myositis"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-0061","authenticated-orcid":false,"given":"Vinojini","family":"Vivekanandam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-6699","authenticated-orcid":false,"given":"Enrico","family":"Bugiardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashirwad","family":"Merve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Parton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-8539","authenticated-orcid":false,"given":"Jasper M.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ncl.2020.03.014_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.ncl.2020.03.014_bib2","first-page":"127","article-title":"A\u00a0systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis","volume":"4","author":"Callan","year":"2017","journal-title":"J\u00a0Neuromuscul Dis"},{"issue":"12","key":"10.1016\/j.ncl.2020.03.014_bib3","first-page":"1448","article-title":"Inclusion body myositis: clinical features and clinical course of the disease in 64 patients","volume":"252","author":"Badrising","year":"2005","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2020.03.014_bib4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/03007995.2018.1486294","article-title":"Health care costs and comorbidities for patients with inclusion body myositis","volume":"34","author":"Keshishian","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.014_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12976-019-0114-4","article-title":"Development and validation of a Bayesian survival model for inclusion body myositis","volume":"16","author":"Capkun","year":"2019","journal-title":"Theor Biol Med Model"},{"issue":"4","key":"10.1016\/j.ncl.2020.03.014_bib6","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","article-title":"Follistatin gene therapy for sporadic inclusion body myositis improves functional outcomes","volume":"25","author":"Mendell","year":"2017","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.ncl.2020.03.014_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","article-title":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Hanna","year":"2019","journal-title":"Lancet Neurol"},{"issue":"331","key":"10.1016\/j.ncl.2020.03.014_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/scitranslmed.aad4583","article-title":"Targeting protein homeostasis in sporadic inclusion body myositis","volume":"8","author":"Ahmed","year":"2016","journal-title":"Sci Transl Med"},{"unstructured":"Benveniste O, Hogrel J-Y, Annoussamy M, et\u00a0al. Rapamycin Vs. Placebo for the treatment of inclusion body myositis: improvement of the 6\u00a0min walking distance, a functional scale, the FVC and muscle quantitative MRI [abstract]. ACR\/ARHP Annu Meet. 2017:11\u20132. Available at: http:\/\/www.myositis.org\/storage\/documents\/IBM_Published_Research\/Rapamycin_Vs_Placebo_for_the_Treatment_of_Inclusion_Body_Myositis_ACR_abstract_2017.pdf. Accessed February 10, 2020.","key":"10.1016\/j.ncl.2020.03.014_bib9"},{"issue":"3","key":"10.1016\/j.ncl.2020.03.014_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00455-011-9384-7","article-title":"Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature","volume":"27","author":"Langdon","year":"2012","journal-title":"Dysphagia"},{"issue":"11","key":"10.1016\/j.ncl.2020.03.014_bib11","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ncl.2020.03.014_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2013.02.010","article-title":"Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials","volume":"23","author":"Cortese","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.ncl.2020.03.014_bib13","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A\u00a012-year follow-up in sporadic inclusion body myositis: An end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2020.03.014_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00455-011-9338-0","article-title":"Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence","volume":"27","author":"Mulcahy","year":"2012","journal-title":"Dysphagia"},{"issue":"11","key":"10.1016\/j.ncl.2020.03.014_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/PHM.0b013e31818a50e2","article-title":"Dysphagia in inclusion body myositis","volume":"87","author":"Oh","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.ncl.2020.03.014_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.bor.0000434671.77891.9a","article-title":"Update in inclusion body myositis","volume":"25","author":"Machado","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.ncl.2020.03.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-015-0541-0","article-title":"Myositis mimics","volume":"17","author":"Michelle","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"9869","key":"10.1016\/j.ncl.2020.03.014_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","article-title":"Muscular dystrophies","volume":"381","author":"Mercuri","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ncl.2020.03.014_bib19","first-page":"838","article-title":"Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients","volume":"30","author":"Dobloug","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"JUN","key":"10.1016\/j.ncl.2020.03.014_bib20","first-page":"1","article-title":"The diagnostic value of MRI pattern recognition in distal myopathies","volume":"9","author":"Bugiardini","year":"2018","journal-title":"Front Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:17Z","timestamp":1760005037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0733861920300359"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.014","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Diagnoses of Inclusion Body Myositis","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}